tiprankstipranks
Trending News
More News >
Eterna Therapeutics (ERNA)
NASDAQ:ERNA
US Market
Advertisement

Eterna Therapeutics (ERNA) Revenue

Compare
266 Followers

Eterna Therapeutics Revenue

Eterna Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 535.00K, Increased -8.08%. In the fiscal year ending Dec 31, 2024, Eterna Therapeutics had annual revenue of 582.00K with 755.88% growth.
Revenue (ttm)
535.00K
Revenue Growth
P/S Ratio
27.95
Revenue/Employee
$97,000
Employees
6
Market Cap
$16.27M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
582.00K514.00K+755.88%
Dec 31, 2023
68.00K+∞%
Dec 31, 2022
0.00
Dec 31, 2021
0.00
Dec 31, 2020
0.00-19.81M-100.00%
Dec 31, 2019
19.81M-3.53M-15.12%
Dec 31, 2018
23.34M2.06M+9.69%
Dec 31, 2017
21.27M-1.04M-4.65%
Dec 31, 2016
22.31M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis